For the first study, published yesterday in eClinicalMedicine, an international roster of researchers in the INTERCOVID consortium mined data from 6,527 pregnant women with and without a COVID-19 ...

COVID-19 cases and hospitalizations are on the rise again ahead of the busy holiday travel season. Dr. Eric Cioe-Peña joins CBSN to discuss what this means for families planning to gather this ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has found that COVID-19 vaccination during pregnancy, particularly when ...

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

The U.S. Food and Drug Administration has authorized booster shots of the Moderna and Pfizer COVID-19 vaccines for all adults ages 18 and older. On Friday, the FDA announced it had amended the ...

Now that the federal government is recommending that many COVID-vaccinated Americans receive booster shots starting this fall, it’s important to know what a “booster” is and how it differs from a ...

NEW BRUNSWICK, N.J. -- Booster doses of Johnson & Johnson's one-shot coronavirus vaccine generated a big spike in antibodies, the frontline immune system defenses against infection, the company ...

It is now up to the CDC to decide whether to roll out booster shots for Moderna and Johnson & Johnson vaccine recipients, after the FDA authorized the additional doses Wednesday. The FDA also signed ...